Skip to main content
Erschienen in: Obesity Surgery 11/2020

19.06.2020 | Original Contributions

Biliopancreatic Diversion in the Surgical Treatment of Morbid Obesity: Long-Term Results and Metabolic Consequences

verfasst von: Alessandro Bianchi, Alberto Pagan-Pomar, Marina Jimenez-Segovia, José Antonio Martinez-Corcoles, Francesc Xavier Gonzalez-Argenté

Erschienen in: Obesity Surgery | Ausgabe 11/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

In the multidisciplinary therapeutic approach to obesity, bariatric surgery is considered the most effective treatment in weight reduction and the decrease in associated comorbidities. The objective of this work is to describe the long-term clinical and metabolic results in obese patients undergoing biliopancreatic diversion (BPD) according to Scopinaro’s technique.

Materials and Methods

Patients undergoing surgery were followed by the same multidisciplinary team in a study period of 15 years (1999–2015). A retrospective study based on a prospective database was designed, where data on the evolution of obesity-related diseases and nutritional parameters were studied.

Results

Two hundred seventy-seven patients were collected; 75.5% were women. The preoperative body mass index (BMI) decreased from 52.5 kg/m2 to 34.9 kg/m2 10 years after surgery. A resolution or improvement of diabetes has been observed in 85.38% of the patients; a decrease in arterial hypertension and obstructive sleep apnea syndrome were in 65.61% and 89.14%, respectively. Throughout the monitoring of the sample, protein malnutrition increased, from 1.8% after the first year of surgery to 4.5% 10 years after the operation.

Conclusion

Even if Scopinaro’s technique is beginning to be replaced by other malabsorptive techniques, it can still be considered as an effective surgical procedure in terms of weight loss, quality of life, and evolution of obesity-related diseases. In order to avoid nutritional deficiencies, the operated patients need a strict follow-up and a supplementation adjusted to the technique.
Literatur
2.
Zurück zum Zitat Lecube A, Monereo S, Rubio MÁ, et al. Prevention, diagnosis, and treatment of obesity. 2016 position statement of the Spanish Society for the Study of Obesity. Endocrinol Diabetes Nutr. 2017;64(Suppl 1):15–22.PubMedCrossRef Lecube A, Monereo S, Rubio MÁ, et al. Prevention, diagnosis, and treatment of obesity. 2016 position statement of the Spanish Society for the Study of Obesity. Endocrinol Diabetes Nutr. 2017;64(Suppl 1):15–22.PubMedCrossRef
3.
4.
Zurück zum Zitat Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(3):248–256.e5.PubMedCrossRef Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(3):248–256.e5.PubMedCrossRef
5.
Zurück zum Zitat English WJ, DeMaria EJ, Hutter MM, et al. American Society for Metabolic and Bariatric Surgery 2018 estimate of metabolic and bariatric procedures performed in the United States. Surg Obes Relat Dis. 2020; English WJ, DeMaria EJ, Hutter MM, et al. American Society for Metabolic and Bariatric Surgery 2018 estimate of metabolic and bariatric procedures performed in the United States. Surg Obes Relat Dis. 2020;
6.
Zurück zum Zitat Gagner M. For whom the bell tolls? It is time to retire the classic BPD (bilio-pancreatic diversion) operation. Surg Obes Relat Dis. 2019 Jun;15(6):1029–31.PubMedCrossRef Gagner M. For whom the bell tolls? It is time to retire the classic BPD (bilio-pancreatic diversion) operation. Surg Obes Relat Dis. 2019 Jun;15(6):1029–31.PubMedCrossRef
7.
Zurück zum Zitat Ballesteros-Pomar MD. González de Francisco T, Urioste-Fondo a, González-Herraez L, Calleja-Fernández a, Vidal-Casariego a, et al. Biliopancreatic diversion for severe obesity: long-term effectiveness and nutritional complications. Obes Surg. 2015; Ballesteros-Pomar MD. González de Francisco T, Urioste-Fondo a, González-Herraez L, Calleja-Fernández a, Vidal-Casariego a, et al. Biliopancreatic diversion for severe obesity: long-term effectiveness and nutritional complications. Obes Surg. 2015;
8.
Zurück zum Zitat Topart P, Becouarn G, Salle A. Five-year follow-up after biliopancreatic diversion with duodenal switch. Surg Obes Relat Dis. 2011;7(2):199–205.PubMedCrossRef Topart P, Becouarn G, Salle A. Five-year follow-up after biliopancreatic diversion with duodenal switch. Surg Obes Relat Dis. 2011;7(2):199–205.PubMedCrossRef
9.
Zurück zum Zitat Skroubis G, Kouri N, Mead N, et al. Long-term results of a prospective comparison of Roux-en-Y gastric bypass versus a variant of biliopancreatic diversion in a non-superobese population (BMI 35-50 kg/m(2)). Obes Surg. 2014;24(2):197–204.PubMedCrossRef Skroubis G, Kouri N, Mead N, et al. Long-term results of a prospective comparison of Roux-en-Y gastric bypass versus a variant of biliopancreatic diversion in a non-superobese population (BMI 35-50 kg/m(2)). Obes Surg. 2014;24(2):197–204.PubMedCrossRef
10.
Zurück zum Zitat Gracia JA, Martínez M, Elia M, et al. Obesity surgery results depending on technique performed: long-term outcome. Obes Surg. 2009;19(4):432–8.PubMedCrossRef Gracia JA, Martínez M, Elia M, et al. Obesity surgery results depending on technique performed: long-term outcome. Obes Surg. 2009;19(4):432–8.PubMedCrossRef
11.
Zurück zum Zitat Scopinaro N, Gianetta E, Civalleri D, et al. Bilio-pancreatic bypass for obesity: II. Initial experience in man. Br J Surg. 1979;66(9):618–20.PubMedCrossRef Scopinaro N, Gianetta E, Civalleri D, et al. Bilio-pancreatic bypass for obesity: II. Initial experience in man. Br J Surg. 1979;66(9):618–20.PubMedCrossRef
12.
Zurück zum Zitat Tabesh MR, Maleklou F, Ejtehadi F, et al. Nutrition, physical activity, and prescription of supplements in pre- and post-bariatric surgery patients: a practical guideline. Obes Surg. 2019;29(10):3385–400.PubMedCrossRef Tabesh MR, Maleklou F, Ejtehadi F, et al. Nutrition, physical activity, and prescription of supplements in pre- and post-bariatric surgery patients: a practical guideline. Obes Surg. 2019;29(10):3385–400.PubMedCrossRef
13.
Zurück zum Zitat Rachlin E, Galvani C. Metabolic surgery as a treatment option for type 2 diabetes mellitus: surgical view. Curr Diab Rep. 2018;18(11):113.PubMedCrossRef Rachlin E, Galvani C. Metabolic surgery as a treatment option for type 2 diabetes mellitus: surgical view. Curr Diab Rep. 2018;18(11):113.PubMedCrossRef
14.
Zurück zum Zitat Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9.PubMedCrossRef Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9.PubMedCrossRef
15.
Zurück zum Zitat Swails WS, Samour PQ, Babineau TJ, et al. A proposed revision of current ICD-9-CM malnutrition code definitions. J Am Diet Assoc. 1996;96(4):370–3.PubMedCrossRef Swails WS, Samour PQ, Babineau TJ, et al. A proposed revision of current ICD-9-CM malnutrition code definitions. J Am Diet Assoc. 1996;96(4):370–3.PubMedCrossRef
16.
Zurück zum Zitat Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292(14):1724–37.PubMedCrossRef Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292(14):1724–37.PubMedCrossRef
17.
Zurück zum Zitat Topart P, Becouarn G, Delarue J. Weight loss and nutritional outcomes 10 years after biliopancreatic diversion with duodenal switch. Obes Surg. 2017;27(7):1645–50.PubMedCrossRef Topart P, Becouarn G, Delarue J. Weight loss and nutritional outcomes 10 years after biliopancreatic diversion with duodenal switch. Obes Surg. 2017;27(7):1645–50.PubMedCrossRef
18.
Zurück zum Zitat Scopinaro N, Camerini G, Papadia F, et al. Long-term clinical and functional impact of biliopancreatic diversion on type 2 diabetes in morbidly and non-morbidly obese patients. Surg Obes Relat Dis. 2016;12(4):822–7.PubMedCrossRef Scopinaro N, Camerini G, Papadia F, et al. Long-term clinical and functional impact of biliopancreatic diversion on type 2 diabetes in morbidly and non-morbidly obese patients. Surg Obes Relat Dis. 2016;12(4):822–7.PubMedCrossRef
19.
Zurück zum Zitat Vidal P, Ramón JM, Goday A, et al. Lack of adherence to follow-up visits after bariatric surgery: reasons and outcome. Obes Surg. 2014;24(2):179–83.PubMedCrossRef Vidal P, Ramón JM, Goday A, et al. Lack of adherence to follow-up visits after bariatric surgery: reasons and outcome. Obes Surg. 2014;24(2):179–83.PubMedCrossRef
21.
Zurück zum Zitat Scopinaro N, Marinari GM, Camerini GB, et al. Specific effects of biliopancreatic diversion on the major components of metabolic syndrome: a long-term follow-up study. Diabetes Care. 2005;28(10):2406–11.PubMedCrossRef Scopinaro N, Marinari GM, Camerini GB, et al. Specific effects of biliopancreatic diversion on the major components of metabolic syndrome: a long-term follow-up study. Diabetes Care. 2005;28(10):2406–11.PubMedCrossRef
22.
Zurück zum Zitat Scopinaro N, Papadia F, Camerini G, et al. A comparison of a personal series of biliopancreatic diversion and literature data on gastric bypass help to explain the mechanisms of resolution of type 2 diabetes by the two operations. Obes Surg. 2008;18(8):1035–8.PubMedCrossRef Scopinaro N, Papadia F, Camerini G, et al. A comparison of a personal series of biliopancreatic diversion and literature data on gastric bypass help to explain the mechanisms of resolution of type 2 diabetes by the two operations. Obes Surg. 2008;18(8):1035–8.PubMedCrossRef
23.
Zurück zum Zitat Scopinaro N, Adami GF, Marinari GM, et al. Biliopancreatic diversion. World J Surg. 1998;22(9):936–46.PubMedCrossRef Scopinaro N, Adami GF, Marinari GM, et al. Biliopancreatic diversion. World J Surg. 1998;22(9):936–46.PubMedCrossRef
25.
Zurück zum Zitat Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the Obesity Society. Circulation. 2014;129(25 Suppl 2):S102–38.PubMedCrossRef Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the Obesity Society. Circulation. 2014;129(25 Suppl 2):S102–38.PubMedCrossRef
26.
Zurück zum Zitat Wolk R, Shamsuzzaman ASM, Somers VK. Obesity, sleep apnea, and hypertension. Hypertension. 2003;42(6):1067–74.PubMedCrossRef Wolk R, Shamsuzzaman ASM, Somers VK. Obesity, sleep apnea, and hypertension. Hypertension. 2003;42(6):1067–74.PubMedCrossRef
27.
Zurück zum Zitat Young T, Skatrud J, Peppard PE. Risk factors for obstructive sleep apnea in adults. JAMA. 2004 Apr 28;291(16):2013–6.PubMedCrossRef Young T, Skatrud J, Peppard PE. Risk factors for obstructive sleep apnea in adults. JAMA. 2004 Apr 28;291(16):2013–6.PubMedCrossRef
28.
Zurück zum Zitat Peppard PE, Young T, Palta M, et al. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA. 2000 Dec 20;284(23):3015–21.PubMedCrossRef Peppard PE, Young T, Palta M, et al. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA. 2000 Dec 20;284(23):3015–21.PubMedCrossRef
29.
Zurück zum Zitat Young T, Peppard PE, Taheri S. Excess weight and sleep-disordered breathing. J Appl Physiol. 2005 Oct;99(4):1592–9.PubMedCrossRef Young T, Peppard PE, Taheri S. Excess weight and sleep-disordered breathing. J Appl Physiol. 2005 Oct;99(4):1592–9.PubMedCrossRef
30.
Zurück zum Zitat Buffington C, Walker B, Cowan GJ, et al. Vitamin D deficiency in the morbidly obese. Obes Surg. 1993;3(4):421–4.PubMedCrossRef Buffington C, Walker B, Cowan GJ, et al. Vitamin D deficiency in the morbidly obese. Obes Surg. 1993;3(4):421–4.PubMedCrossRef
31.
Zurück zum Zitat Chapin BL, LeMar HJ, Knodel DH, et al. Secondary hyperparathyroidism following biliopancreatic diversion. Arch Surg. 1996;131(10):1048–52. discussion 1053PubMedCrossRef Chapin BL, LeMar HJ, Knodel DH, et al. Secondary hyperparathyroidism following biliopancreatic diversion. Arch Surg. 1996;131(10):1048–52. discussion 1053PubMedCrossRef
32.
Zurück zum Zitat Marceau P, Hould FS, Simard S, et al. Biliopancreatic diversion with duodenal switch. World J Surg. 1998;22(9):947–54.PubMedCrossRef Marceau P, Hould FS, Simard S, et al. Biliopancreatic diversion with duodenal switch. World J Surg. 1998;22(9):947–54.PubMedCrossRef
33.
Zurück zum Zitat Switzer NJ, Marcil G, Prasad S, et al. Long-term hypovitaminosis D and secondary hyperparathyroidism outcomes of the Roux-en-Y gastric bypass: a systematic review. Obes Rev. 2017;18(5):560–6.PubMedCrossRef Switzer NJ, Marcil G, Prasad S, et al. Long-term hypovitaminosis D and secondary hyperparathyroidism outcomes of the Roux-en-Y gastric bypass: a systematic review. Obes Rev. 2017;18(5):560–6.PubMedCrossRef
34.
35.
Zurück zum Zitat Scopinaro N. Thirty-five years of biliopancreatic diversion: notes on gastrointestinal physiology to complete the published information useful for a better understanding and clinical use of the operation. Obes Surg. 2012;22(3):427–32.PubMedCrossRef Scopinaro N. Thirty-five years of biliopancreatic diversion: notes on gastrointestinal physiology to complete the published information useful for a better understanding and clinical use of the operation. Obes Surg. 2012;22(3):427–32.PubMedCrossRef
36.
Zurück zum Zitat Avinoah E, Ovnat A, Charuzi I. Nutritional status seven years after Roux-en-Y gastric bypass surgery. Surgery. 1992;111(2):137–42.PubMed Avinoah E, Ovnat A, Charuzi I. Nutritional status seven years after Roux-en-Y gastric bypass surgery. Surgery. 1992;111(2):137–42.PubMed
37.
Zurück zum Zitat Marceau P, Hould FS, Lebel S, et al. Malabsorptive obesity surgery. Surg Clin North Am. 2001;81(5):1113–27.PubMedCrossRef Marceau P, Hould FS, Lebel S, et al. Malabsorptive obesity surgery. Surg Clin North Am. 2001;81(5):1113–27.PubMedCrossRef
38.
Zurück zum Zitat Scopinaro N, Marinari GM, Camerini G. Laparoscopic standard biliopancreatic diversion: technique and preliminary results. Obes Surg. 2002;12(2):241–4.PubMedCrossRef Scopinaro N, Marinari GM, Camerini G. Laparoscopic standard biliopancreatic diversion: technique and preliminary results. Obes Surg. 2002;12(2):241–4.PubMedCrossRef
39.
Zurück zum Zitat de Luis DA, Pacheco D, Izaola O, et al. Clinical results and nutritional consequences of biliopancreatic diversion: three years of follow-up. Ann Nutr Metab. 2008;53(3–4):234–9.PubMedCrossRef de Luis DA, Pacheco D, Izaola O, et al. Clinical results and nutritional consequences of biliopancreatic diversion: three years of follow-up. Ann Nutr Metab. 2008;53(3–4):234–9.PubMedCrossRef
40.
Zurück zum Zitat Mechanick JI, Youdim A, Jones DB, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & bariatric surgery. Endocr Pract. 2013;19(2):337–72.PubMedPubMedCentralCrossRef Mechanick JI, Youdim A, Jones DB, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & bariatric surgery. Endocr Pract. 2013;19(2):337–72.PubMedPubMedCentralCrossRef
41.
Zurück zum Zitat Patel JJ, Mundi MS, Hurt RT, et al. Micronutrient deficiencies after bariatric surgery: an emphasis on vitamins and trace minerals [formula: see text]. Nutr Clin Pract. 2017;32(4):471–80.PubMedCrossRef Patel JJ, Mundi MS, Hurt RT, et al. Micronutrient deficiencies after bariatric surgery: an emphasis on vitamins and trace minerals [formula: see text]. Nutr Clin Pract. 2017;32(4):471–80.PubMedCrossRef
42.
Zurück zum Zitat Furie B, Furie BC. Molecular basis of vitamin K-dependent gamma-carboxylation. Blood. 1990;75(9):1753–62.PubMedCrossRef Furie B, Furie BC. Molecular basis of vitamin K-dependent gamma-carboxylation. Blood. 1990;75(9):1753–62.PubMedCrossRef
43.
Zurück zum Zitat Vázquez C, Morejón E, Muñoz C, et al. Nutritional effect of bariatric surgery with Scopinaro operation. Analysis of 40 cases. Nutr Hosp. 2003;18(4):189–93.PubMed Vázquez C, Morejón E, Muñoz C, et al. Nutritional effect of bariatric surgery with Scopinaro operation. Analysis of 40 cases. Nutr Hosp. 2003;18(4):189–93.PubMed
Metadaten
Titel
Biliopancreatic Diversion in the Surgical Treatment of Morbid Obesity: Long-Term Results and Metabolic Consequences
verfasst von
Alessandro Bianchi
Alberto Pagan-Pomar
Marina Jimenez-Segovia
José Antonio Martinez-Corcoles
Francesc Xavier Gonzalez-Argenté
Publikationsdatum
19.06.2020
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 11/2020
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-020-04777-w

Weitere Artikel der Ausgabe 11/2020

Obesity Surgery 11/2020 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.